Omecamtiv mecarbil: A promising new drug in systolic heart failure

Matthijs F. L. Meijs, Folkert W. Asselbergs, Pieter A. Doevendans

Research output: Contribution to journal › Editorial › Academic › peer-review

12 Citations (Scopus)

Original language	English
Pages (from-to)	232-233
Journal	European journal of heart failure
Volume	14
Issue number	3
DOIs	https://doi.org/10.1093/eurjhf/hfr178
Publication status	Published - Mar 2012
Externally published	Yes

Access to Document

@article{d1ad3d00b63f46f98acd31412f9d63de,

title = "Omecamtiv mecarbil: A promising new drug in systolic heart failure",

author = "Meijs, {Matthijs F. L.} and Asselbergs, {Folkert W.} and Doevendans, {Pieter A.}",

year = "2012",

month = mar,

doi = "https://doi.org/10.1093/eurjhf/hfr178",

language = "English",

volume = "14",

pages = "232--233",

journal = "European journal of heart failure",

issn = "1388-9842",

publisher = "Oxford University Press",

number = "3",

}

TY - JOUR

T1 - Omecamtiv mecarbil

T2 - A promising new drug in systolic heart failure

AU - Meijs, Matthijs F. L.

AU - Asselbergs, Folkert W.

AU - Doevendans, Pieter A.

PY - 2012/3

Y1 - 2012/3

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84857551829&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/22210833

U2 - https://doi.org/10.1093/eurjhf/hfr178

DO - https://doi.org/10.1093/eurjhf/hfr178

M3 - Editorial

C2 - 22210833

SN - 1388-9842

VL - 14

SP - 232

EP - 233

JO - European journal of heart failure

JF - European journal of heart failure

IS - 3

ER -